GPCR/G protein
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
- B5060 Pancreatic Polypeptide (human)Summary: Endogenous high affinity agonist for human NPY Y4 receptor
- B5061 CGRP (rat) TFASummary: Endogenous neuropeptide, potent vasodilator
- B5062 Endothelin 3 (human, rat)Summary: Endogenous neuropeptide with selectivity for the putative ETC endothelin receptor
- B5064 Somatostatin 1-28Summary: Somatostatin receptor agonist
- B5065 [Leu31,Pro34]-Neuropeptide Y (porcine)Summary: High affinity neuropeptide Y Y1 receptor agonist
- B5066 CGRP 8-37 (rat)Summary: Peptide antagonist for CGRP1 receptors
- B5069 Sarafotoxin S6bSummary: non-selective endothelin receptor agonist
- B5070 Sarafotoxin S6cSummary: Highly selective ETB endothelin receptor agonist
- B5073 CGRP 8-37 (human)Summary: Peptide antagonist for CGRP1 receptors
- B5074 VIP (guinea pig)Summary: Neuropeptide with many biological actions